The objective of this study was to evaluate the bioactivity of human chorio
nic gonadotrophin (HCG) during first trimester pregnancy. This was done by
means of a retrospective analysis of sera from patients with first trimeste
r normal intrauterine and ectopic pregnancies, Serum samples were obtained
from 38 women with amenorrhoea of <10 weeks, From these, 19 had a normal in
trauterine pregnancy (IUP) and 19 an ectopic pregnancy (EP), Cases were all
ocated to either low serum immunoreactive HCG (HCGi), intermediate HCGi or
high HCGi concentrations (HCGi <5000 mUI/ml, between 5000 and 40 000 mIU/ml
and >40 000 mIU/mi respectively). HCGi and oestradiol were measured by enz
yme immunoassays and bioactive HCG by the mouse Leydig cell bioassay, All r
esults were analysed by analysis of variance and unpaired Student's t-test,
There was a significant difference between bioactive to immunoreactive HCG
ratios (b/i ratio) between the subgroups of low, intermediate and high HCG
i concentrations. Lower b/i ratios were found when HCGi concentrations were
high (HCG b/i mean +/- SEM: high subgroup, 0.33 +/- 0.07 versus. low subgr
oup: 1.50 +/- 0.12; P < 0.0001), Furthermore, the b/i ratios were inversely
correlated with oestradiol (P < 0.0001) and HCGi (P < 0.0001) concentratio
ns but not with gestational age, There was no difference in the b/i ratios
when comparing IUP with EP. It is concluded that, in first trimester pregna
ncies, there is a likely modulation of HCG bioactivity which is inversely c
orrelated with HCGi and oestradiol concentration. The underlying mechanisms
and their physiological relevance remain to be elucidated.